RFP - Endline Evaluation: Strengthening HIV and Harm Reduction Responses for PWID in Asia (Harm Reduction in Asia)

RFP - Endline Evaluation: Strengthening HIV and Harm Reduction Responses for PWID in Asia (Harm Reduction in Asia)

Organization: India HIV/AIDS Alliance (Alliance India)

Apply By: 23 Oct 2020

Follow us @ngobox

RFP - The Endline Evaluation of the project for “Strengthening HIV and Harm Reduction Responses for PWIDs in Asia”(Harm Reduction Advocacy in Asia)

About the Organization:

India HIV/AIDS Alliance (Alliance India) is a diverse partnership that brings together committed organisations and communities to support sustained responses to HIV in India. Complementing the Indian national programme, they work through capacity building, knowledge sharing, technical support and advocacy. Through their network of partners, they support the delivery of effective, innovative, community-based HIV programmes to key populations affected by the epidemic.

About the Project/Program

Alliance India, with support of the Global Fund to Fight AIDS, Malaria and Tuberculosis (The Global Fund), is implementing a Regional Harm Reduction Advocacy grant in seven countries in Asia. The project is being implemented in Cambodia, India, Indonesia, Nepal, Philippines, Thailand and Vietnam during the period 2017-2020.

With an overall goal to increase access to essential HIV and harm reduction services for the people who use drugs (PWUD), the project is creating an impact on the harm reduction services in the 7 Asian countries by achieving 3 strategic objectives viz:

  • Creating an enabling legal and policy environment that supports the implementation of HIV and harm reduction interventions.
  • Strengthen PWID networks to enable meaningful engagement with national governments and regional mechanisms for a sustained HIV and drug use response.
  • Increase the use of strategic information in shaping evidence and rights-based HIV and HR policies and programs in the activities above

Purpose of the Endline Evaluation

The project is in the fourth year and last phase of its implementation, as per the agreed performance framework with the Global Fund, the Endlinestudy has to be conducted with focus on measuring the outcomes and impact of the project on

  • Enabling environment;
  • policy,
  • law enforcement,
  • Planning, human rights,
  • Community system strengthening,
  • Institutional capacity building,
  • Accessibility to harm reduction services.

The study will analyse project progress since the project baseline and as outlined in the respective Blue Print for Change (BFC). The Endlinestudy shall assess and report the status at the country-specific and regional level.

The objective of the Endline study

The broad objectives proposed for the Endline study are:

  • Critically examine the achievements and weakness of the project including the improvements required in supporting the national governments to create an enabling environment at the legal and policy level to increase financing, access, availability, and quality of HIV and harm reduction services in the Asia region for PWIDs
  • To study the relevance, effectiveness and efficiency of activities like building the capacity of PWID networks and civil society organizations in the region for a meaningful engagement with national governments and regional networks for a sustained HIV and drug use response.
  • To compare and review the change made by the project since the baseline and as outline in the respective BluePrint for Change (BFC) against the identified indicators of country (7) and region-wise.
  • Record the lessons learned, best practices, unintended results, success stories, challenges from the project and comprehensive dissemination plan to inform various stakeholders on the future course of action in providing rights-based and gender-sensitive HIV response to PWID.

The main users of Endline Evaluation

The findings, lessons and recommendations generated in the Endline study will be used by different stakeholders:

  • The Global Fund to plan future programming
  • As evidence to Governments, UN, other development partners for building an effective strategy, including investments and collaboration to addressing the needs of the people infected by HIV and PWID.
  • The partner NGOs, networks and beneficiary community will also benefit from this evaluation to develop approaches to collaborate, participate, and support the HIV response for PWIDs.

Scope and methodology of the Endline Evaluation

  • The scope of the evaluation is limited to project activities in seven selected countries in Asia: Cambodia, India, Indonesia, Nepal, Philippines, Thailand and Vietnam. The evaluation will cover the implementation period from January 2017 to 2020.
  • The evaluation team will review project documents and relevant reports ie. Blueprint for Change (BFC), GAC submission document, Baseline survey report,country papers, etc and develop an inception report along with study methodology to share with Alliance India for further briefing and finalization.
  • The evaluation team in consultation with Alliance India will plan the countries to be visited or virtually contactas an alternative due to COVID 19 restriction during the Inception Phase.
  • Followed by the inception report, after primary and secondary data collection a draft evaluation report will be submitted, and subsequently finalized in consultation with Alliance India.
  • The consultant(s)/agencies will draw up a list of stakeholders to be engaged in the endline evaluation in consultation with Alliance india.
  • The consultant(s)/agencies will disseminate the evaluation findings with the stakeholders at the end of the consulting period.
  • The level of engagement of the evaluators with stakeholders may vary accordingly and may include telephonic In-depth Interviews as well as virtual surveys.
  • The consultant(s)/agencies are expected to provide the details of the proposed quality control mechanism at all levels of study, including inception, data collection, preparation, data entry, analysis and report writing.

Expected Outputs/Outcomes of the Endline Evaluation:

  • Study protocol including study design and methodology
  • Ethical approval for the study
  • Data collection tools
  • Soft copy of all the documents to be reviewed with complete referencing and Inventory
  • Framework for desk review (with themes and sub-themes)
  • Properly labelled data sets (both quantitative and qualitative, as applicable)
  • Content analysis format(s) and Data maps
  • One final report with sections on regional and country level progress

These Terms of Reference may vary to reflect the changing needs of The Global Fund and Alliance India. This will be done in consultation with the research agency/individual consultant/team of consultants. The research team will be expected to work in a flexible and adaptable manner, responding to changing needs, priorities and context.

Queries in respect of RFP are to be sent only to procurement@allianceindia.org latest by 19th October 2020 by 5:00 PM

Deadline: 23rd October 2020 by 5.00 pm

For more information please check the Link



© Renalysis Consultants Pvt Ltd